AVRA Medical Robotics, Inc. announced that it has retained The Horizon Phoenix Group and its principal Mr. Timothy K. Duggins as a regulatory consultant. The company entered into a four-year contract to conduct regulatory work on behalf of AVRA. The Horizon Phoenix Group has commenced its services on behalf of AVRA and has since initiated a dialogue with the Food and Drug Administration (FDA), prepared and filed an application for AVRA’s fully autonomous surgical robotic system with the FDA. Now that the application has been filed, the company has proceeded to request its first meeting with the FDA.